Vitamin D Serum Concentrations & Supplementation in Children With Cerebral Palsy
1 other identifier
observational
115
0 countries
N/A
Brief Summary
The purpose of this study is to try to correlate vitamin D dosing and dosing adjustment with Vitamin D levels, measure affects of seizure medications on levels as well as pathologic fractures and bone density in severely cognitively impaired, non-mobile children and adolescents with CP.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2013
CompletedFirst Submitted
Initial submission to the registry
August 19, 2013
CompletedFirst Posted
Study publicly available on registry
August 21, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedJanuary 29, 2016
January 1, 2016
2.5 years
August 19, 2013
January 28, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Change in serum vitamin D concentrations
5 years
Study Arms (1)
Vitamin D supplementation
Eligibility Criteria
Severely cognitively impaired, non-mobile children and young adults who are residents at long-term care facility
You may qualify if:
- Recorded vitamin D supplementation dose (i.e. prescribed diet and any additional sources of vitamin D) with at least two serum vitamin D concentrations recorded in the medical chart from January 1, 2008 to June 30, 2013.
- Resident of HLCCD since 2008
You may not qualify if:
- No vitamin D levels recorded.
- History of hyperthyroidism or parathyroid pathology.
- Short gut syndrome that requires TPN.
- Poor medical documentation.
- Heritable disorders that affect vitamin D levels such as Pseudovitamin D deficiency rickets, Vitamin D resistant rickets, autosomal dominant hypophosphatemic rickets and X-linked hypophosphatemic rickets
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PharmD
Study Record Dates
First Submitted
August 19, 2013
First Posted
August 21, 2013
Study Start
June 1, 2013
Primary Completion
December 1, 2015
Last Updated
January 29, 2016
Record last verified: 2016-01